Physician

Kimberley R. Lovelace, MD

According to 2025 Medicare claims, Kimberley Lovelace, MD (NPI: 1629293493) practices ophthalmology in the Janesville-Beloit, WI market, with the plurality of this provider's patient population coming from Rock, WI. This provider's primary affiliated billing organization is MERCY HEALTH SYSTEM CORPORATION (NPI: 1598718603; TIN: 390816848) and primary practice location at 53546-1626. Lovelace is affiliated with the Mercy Health Corporation (ACO ID: A2097), participating under the MSSP model.

Lovelace's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 489 traditional Medicare patients, billed 1,176 HCPCS/CPT codes, and received $110,399 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 793 prescription claims across 192 beneficiaries totaling $124,334 in drug costs, led by Restasis (Cyclosporine). 2022 DME data shows 14 claims. Open Payments data shows 5 records totaling $1,332. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $142,594 and ending at $110,399. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $130,518 to $124,334. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	827	2,338	$142,594
2016	899	2,347	$164,147
2017	463	931	$81,162
2018	327	916	$109,826
2019	394	1,073	$130,714
2020	317	827	$97,725
2021	368	1,018	$118,127
2022	482	1,243	$110,877
2023	500	1,251	$108,548
2024	489	1,176	$110,399

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	326	1,944	$130,518
2016	355	2,222	$127,990
2017	258	1,280	$75,539
2018	70	186	$14,616
2019	76	200	$24,683
2020	64	195	$25,936
2021	76	208	$44,781
2022	215	674	$133,814
2023	206	859	$149,517
2024	192	793	$124,334

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	52	52	$3,622
2016	95	98	$6,023
2017	49	51	$3,109
2018	14	14	$788
2019	14	14	$750
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	13	14	$791
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	339	355	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	94	107	$43
92136	Measurement of corneal curvature and depth of eye	78	129	$22
92083	Exam of visual field with extended testing	105	106	$18
92133	Imaging of optic nerve	99	99	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	14	1,185	$25,253
Lumigan	Bimatoprost	24	1,700	$16,408
Cyclosporine	Cyclosporine	24	975	$13,123
Cequa	Cyclosporine	13	570	$10,627
Latanoprost	Latanoprost	321	21,392	$5,607

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$1,332	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kimberley R. Lovelace, MD?

Tedicare shows public-source Medicare data for Kimberley R. Lovelace, MD (NPI 1629293493), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberley R. Lovelace, MD have ACO affiliation data?

Kimberley R. Lovelace, MD is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097).

What billing organization is linked to Kimberley R. Lovelace, MD?

Kimberley R. Lovelace, MD is linked to MERCY HEALTH SYSTEM CORPORATION (billing NPI 1598718603) in the available physician profile data.

Does Kimberley R. Lovelace, MD have Open Payments data?

Kimberley R. Lovelace, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.